(NasdaqGM:OCUL), BEDFORD, Mass., Oct. 28, 2025 (GLOBE NEWSWIRE) — Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), an integrated biopharmaceutical company committed to redefining the retina experience, today announced that it plans to host a conference call and webcast on Tuesday, November 4, 2025 at 8:00 AM ET to discuss recent business progress and financial results for […]

Discovery and development of the first systemic therapeutics to deliver self-antigens directly to the thymus to harness the body's natural mechanism to induce central tolerance Lead program in Type 1 diabetes is advancing toward the clinic, with pipeline opportunities in a broad range of autoimmune diseases Company appoints Jason F. Cole, experienced biotech leader and

(Neo:VRNO.NE),(OTC US:VRNOF),(OtherOTC:VRNOF), CHICAGO, Oct. 28, 2025 (GLOBE NEWSWIRE) — Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced that the plan the Company previously outlined to redomicile Verano Holdings Corp. from British Columbia, Canada, to the State of Nevada was approved by shareholders at the

(NASDAQ:BVS), DURHAM, N.C., Oct. 28, 2025 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report financial results for the third quarter of fiscal year 2025 before the market opens on Tuesday, November 4, 2025. The Company's management will host

(NYSE:COLD), ATLANTA, GA., Oct. 28, 2025 (GLOBE NEWSWIRE) — Americold, a global leader in temperature-controlled logistics, real estate, and value-added services, today announced that its Dublin facility has been certified by Ireland's Department of Agriculture, Food and the Marine (DAFM) to export to the United States. This certification makes Americold the only dedicated third-party cold

(NasdaqGM:CSTL), FRIENDSWOOD, Texas, Oct. 28, 2025 (GLOBE NEWSWIRE) — Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that its executive management is scheduled to present a company overview at the Stephens 27th Annual Investment Conference on Wednesday, Nov. 19, 2025, at 10:00 a.m. Eastern time.

(NasdaqGM:TRDA), BOSTON, Oct. 28, 2025 (GLOBE NEWSWIRE) — Entrada Therapeutics, Inc. (Nasdaq: TRDA) today announced the Company will participate in two upcoming investor conferences. Jefferies Global Healthcare Conference in LondonDipal Doshi, Chief Executive Officer, will deliver a company presentation on Tuesday, November 18, 2025, at 5:00 p.m. Greenwich Mean Time in London. 8th Annual Evercore

(NasdaqGM:CLMB), EATONTOWN, N.J., Oct. 28, 2025 (GLOBE NEWSWIRE) — Climb Channel Solutions, an international specialty technology distributor and wholly owned subsidiary of Climb Global Solutions, Inc. (NASDAQ: CLMB) announced the launch of their partnership with Halcyon, the leading anti-ransomware solution provider. The partnership expands Halcyon's reach across thousands of value-added resellers (VARs) and managed service

(NASDAQ:LFCR),(SWX:PPGN.SW), CHASKA, Minn. and TORRANCE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) — Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), and PolyPeptide Laboratories, Inc. (“PolyPeptide”), a global leader in peptide contract development and manufacturing, today announced the signing of a collaboration agreement aimed at providing an integrated, end-to-end

(TSX-V:ABI),(OTC US:ABMBF),(Other OTC:ABMBF), ROUYN-NORANDA, Quebec, Oct. 28, 2025 (GLOBE NEWSWIRE) — Abcourt Mines Inc. (“Abcourt” or the “Corporation”) (TSX Venture: ABI) (OTCQB : ABMBF) is pleased to announce the receipt of its environmental certificate of authorization for custom milling of ore from off-site deposits at its Sleeping Giant mill. This certificate of authorization allows Abcourt